SCHEMBL4654087

SCHEMBL4654087

O=CCc1ccc2nc(Oc3ccc(Oc4ccccc4)cc3)sc2c1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.49
CYP3A4 P08684 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C19 P33261 1/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
TP53 P04637 1/20 0.49
MAPT P10636 1/20 0.49
HTT P42858 1/20 0.49
LTA4H P09960 13/20 0.46
KCNH2 Q12809 5/20 0.45
EPHX2 P34913 1/20 0.42
SCN4A P35499 1/20 0.41
SCN9A Q15858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4655320 0.84 POLB (0.39) SMN1; SMN2CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL4689887 0.84 CYP1A2 (0.60) SMN1; SMN2CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL4654246 0.82 SMN1; SMN2 (0.52) SMN1; SMN2CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL12967445 0.75 KDM4E (0.60) SMN1; SMN2NPC1RAB9ATDP1L3MBTL1
SCHEMBL4519276 0.74 SMN1; SMN2 (0.62) SMN1; SMN2CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL3719408 0.74 LTA4H (0.47) SMN1; SMN2NPC1RAB9AL3MBTL1HTT
SCHEMBL2622431 0.74 L3MBTL1 (0.55) SMN1; SMN2CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL15252862 0.74 SMN1; SMN2 (0.51) SMN1; SMN2CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL11816742 0.74 MAPT (0.57) SMN1; SMN2CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL13588690 0.74 SMN1; SMN2 (0.50) SMN1; SMN2CYP3A4CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1996567-A2 NOVEL ACETYL-COA CARBOXYLASE (ACC) INHIBITORS AND THEIR USE IN DIABETES, OBESITY AND METABOLIC SYNDROME ABBOTT LABORATORIES (US) 2008-12-03 EP disclosed
WO-2007095601-A2 NOVEL ACETYL-COA CARBOXYLASE (ACC) INHIBITORS AND THEIR USE IN DIABETES, OBESITY AND METABOLIC SYNDROME ABBOTT LABORATORIES (US) 2007-08-23 WO disclosed